The cholinergic system plays a major anti-inflammatory role in many diseases through acetylcholine (Ach) release after vagus nerve stimulation. Osteoarthritis (OA) is associated with local low-grade inflammation, but the regulatory mechanisms are unclear. Local Ach release could have anti-inflammatory activity since articular cells express Ach receptors involved in inflammatory responses. Using the 3DISCO clearing protocol that allows whole-sample 3-dimensional (3D) analysis, we cleared human OA cartilage-subchondral bone samples to search for cholinergic nerve fibres able to produce Ach locally. We analysed 3 plugs of knee cartilage and subchondral bone from 3 OA patients undergoing arthroplasty. We found no nerves in the superficial and intermediate articular cartilage layers, as evidenced by the lack of Peripherin staining (a peripheral nerves marker). Conversely, peripheral nerves were found in the deepest layer of cartilage and in subchondral bone. Some nerves in the subchondral bone samples were cholinergic because they coexpressed peripherin and choline acetyltransferase (ChAT), a specific marker of cholinergic nerves. However, no cholinergic nerves were found in the cartilage layers. It is therefore feasible to clear human bone to perform 3D immunofluorescence. Human OA subchondral bone is innervated by cholinergic fibres, which may regulate local inflammation through local Ach release.
Osteoarthritis (OA) is the most common joint disease and is a considerable burden on quality of life due to joint pain, stiffness and loss of function1. OA is mostly characterized by cartilage degradation but is now considered a whole-joint disease associated with subchondral bone remodelling and synovitis. Articular cartilage is composed of several layers, and the deepest layer, called calcified cartilage, is located on top of subchondral bone. Articular cartilage is a unique tissue that is not innervated or vascularized. Communication between subchondral bone and calcified cartilage is needed for cartilage homeostasis. Such communication is also involved in the OA process because of the circulation of soluble mediators from subchondral bone to cartilage undergoing alterations2. Interplay between subchondral bone and deep cartilage may involve micro-cracks at the junction between the two tissues as well as neoangiogenesis of the calcified cartilage, which could be directly involved in OA pathophysiology3,4,5. Additionally, neurogenesis may play a role in OA pathophysiology. Walsh and colleagues previously showed that during OA, peripheral sensory and sympathetic nerves grow in calcified cartilage and may be involved in OA pain6,7.
Beyond sensory mediators and sensory nerves, the parasympathetic system has been reported to have anti-inflammatory properties through the action of its mediator, acetylcholine (Ach), on nicotinic Ach receptors and, in particular, the alpha7 nicotinic receptor8,9. Ach production is controlled by choline acetyltransferase (ChAT), which is mainly recognized as a marker of cholinergic nerves. Because Ach interacts locally with nicotinic Ach and muscarinic receptors expressed by resident cells of the bone to exert anti-inflammatory effects, we wondered whether cholinergic nerves are locally expressed in subchondral bone10,11. Because it is challenging to characterize nerve structures using two-dimensional (2D) techniques with confocal microscopy, we adapted a recently published protocol for the three-dimensional (3D) analysis of immunofluorescence12,13. 3D immunolabelling allows the study of anatomical structures while preserving the whole structure of the tissue sample. This method was first developed in neuroscience for studying the mouse brain and spinal cord and then for studying embryonic development in humans13. Improvements in light sheet microscopy and the clearing protocol have made it possible to readily immunolabel a whole tissue sample in a straightforward manner. Therefore, this technique is of interest for the study of small structures, such as nerves. One challenging step is clearing bone because it is rich in adipose tissue and because decalcification techniques complicate the protocol and may limit its success. Several teams have managed to clear murine bone in different stages of differentiation, but until now, no one has managed to clear human adult bone14,15. The objective of our study was to determine the presence of cholinergic nerves in cartilage and subchondral OA human samples using 3D immunolabelling.
The 3DISCO clearing protocol enabled human OA subchondral bone immunofluorescence
We first used one sample to establish that plugs of a particular size could be analysed by microscopy, and we confirmed that all cartilage layers and sufficient subchondral bone were present for analysis (Fig. 1A,B). Then, we performed immunofluorescence on three independent samples from patients aged 68 to 79 years, 1 woman and two men, with a body mass index between 32 and 38 kg/m2. We first confirmed that the clearing method of cartilage-subchondral bone samples worked using the 3DISCO protocol. We found that the 3DISCO protocol allowed us to macroscopically clear all subchondral bone (Fig. 1C) and to precisely analyse the anatomical structure of trabecular bone, allowing us to differentiate trabecular bone and bone marrow, as shown in Fig. 2. We confirmed that immunofluorescence was an efficient technique for localizing peripheral nerves in the 3 samples using peripherin labelling (Fig. 3, Supplementary video 1). The nerve density appeared to be similar in the 3 samples. All the nerves appeared to come from the epiphyseal region of the bone and cross all the subchondral bone to reach the cartilage. Indeed, as expected, no nerves were present in superficial and the intermediate cartilage, although some peripherin-positive nerve fibres had invaded deeper layers of cartilage in the 3 samples (Fig. 3, Supplementary video 1).
Cholinergic peripheral nerves are present in human OA subchondral bone
In the three independent human OA samples, some of the peripheral nerves coexpressed ChAT, meaning that some of the fibres may produce ACh and thus belong to the cholinergic nervous system (Fig. 4, Supplementary video 2). However, we did not find any cholinergic nerves in any of the cartilage layers. No nerves structures or cholinergic nerves was shown in the two negative controls that we performed (one without any antibody and one with the secondary antibody at the same concentration) as shown in the Supplementary Files 3.
We report for the first time that cholinergic fibres are present in human OA subchondral bone. Furthermore, we show that a clearing protocol for cartilage-subchondral bone samples is feasible and enables 3D immunolabelling of these human tissues. This study opens new avenues of research in bone analysis and will allow the qualitative and quantitative analysis of anatomical structures in human diseases.
Parasympathetic innervation of joint tissues has been less studied than its sympathetic counterpart. Bajayo et al. successfully demonstrated parasympathetic innervation of rat bone by injecting a labelled neurogenic pseudorabies virus into the metaphyseal region of a rat femur to label parasympathetic sacral centres16. However, these researchers did not confirm their results in human samples. Others have reported the presence of cholinergic fibres in the periosteum of rats based on expression of vesicular Ach transporter (VAchT) or ChAT17. Cholinergic fibres have also been found in periarticular tissues (mostly skin and muscle) from mice with arthritis, which have decreased sympathetic fibre density. VAchT-positive fibres were also found in very few synovia of OA and rheumatoid arthritis patients18. The presence of cholinergic fibres does not necessarily indicate the presence of a complete parasympathetic system, as these fibres could arise from sympathetic fibres by modifying their phenotype. In the periosteum, cholinergic fibres are derived from catecholaminergic fibres in response to local neuropoietic cytokines, such as leukaemia inhibitory factor, which is produced locally by osteoclasts or osteoblasts17,18,19,20. These apparent cholinergic fibres in subchondral bone could arise from sympathetic rather than parasympathetic centres. Despite the final anatomical provenance of the nerve, the presence of cholinergic nerves indicates the local production of Ach, which can be modulated and can act on nicotinic and/or muscarinic cholinergic receptors to exert anti-inflammatory and immunomodulatory activity or to modulate bone mass, which is of interest for future research in osteoporosis10,21,22. However, this study did not allow to quantify these cholinergic nerves and to correlate such a quantification with OA severity and our results involve only healthy macroscopically zone of human OA subchondral bone. Furthermore, we cleared and immunolabelled 3D human subchondral bone for the first time. Clearing some tissues remains a challenge and constitutes a limiting step for 3D immunolabelling. The principle of clearing is to modify the refractive index of the tissue by changing its composition; this is accomplished by removing the lipids and then immersing the samples in a clearing medium to achieve a uniform refractive index. Several clearing protocols have been published in the last decade23; the most commonly used protocols are the 3DISCO and iDISCO protocols, which both employ the same optical clearing approach and a dibenzyl ether-based technique24,25. Not all antibodies are compatible with clearing protocol. However, we have used two antibodies already used with this method and published13. Thus, this antibody of ChAT stained motoneurons on human embryos (https://transparent-human-embryo.com/?p=863). However, although filtered, the immunostaining of ChAT was slightly alterated with the presence of non-specific labelling. Since these artefacts were not found when the sample was incubated with the secondary antibody alone, it is likely that they were due to the primary antibody. Another explanation could have been the expression of a non-neuronal cholinergic system by non-neuronal cells in the bone but it would have led to much more staining in the entire sample.
We demonstrated that the 3DISCO protocol is feasible and can be used for future research on nerve and vessels in joint tissues as well as for cell marker labelling.
In conclusion, cholinergic fibres are found in the macroscopically healthy area of the human OA subchondral bone as to deliver locally Ach. The 3D clearing protocol developed for human cartilage and bone allows the analysis of whole cartilage-bone samples of 10 mm2 without sectioning.
Four independent human OA samples were isolated from the knees of patients undergoing joint arthroplasty for OA at AP-HP Saint-Antoine Hospital (Paris, France). Informed consent for the use of tissue was obtained from each patient before surgery. Experiments using human samples were approved by a French Institutional Review Board (Comité de Protection des Personnes, Paris Ile de France 5 and Commission Nationale de l’Informatique et des Libertés). All experiments were performed in accordance with relevant guidelines and regulations. Just after the surgery, small 10-mm2 plugs of human OA cartilage and subchondral were obtained. Each plug was taken from a macroscopically healthy area of the joint and included the entire cartilage layer and a piece of subchondral bone just below the cartilage. Samples were fixed at 4 °C for 24 hours in 4% paraformaldehyde diluted in PBS and then decalcified in 500 mM EDTA (pH 7.4, VWR, Pennsylvania, USA) diluted in PBS for approximately 4 weeks at 4 °C in a rotating wheel. The EDTA solution was changed every 48 hours until the samples were considered decalcified (approximately 4 weeks). One sample was used for standard histological analysis and embedded in paraffin. Sagittal sections of 5 µm were obtained, and one slide was stained with Safranin O/Fast Green for the analysis of cartilage layers and subchondral bone structure. For 3D immunofluorescence, the three other samples were rinsed three times in PBS before being dehydrated in a series of methanol/PBS (50% methanol/PBS, 80% methanol/PBS and 100% methanol) at room temperature for 1.5 hours. The samples were incubated overnight at 4 °C in the dark in the bleaching solution (methanol and 6% H2O2) and then rehydrated in the opposite series of methanol/PBS. Then, the samples were blocked and permeabilized in 1X PBS-0.2% gelatin-0.5% Triton (PBSGT) for 48 hours. We next incubated the samples with primary antibodies against peripherin (1:500 dilution, #AB1530, Merck Millipore, Massachusetts, USA) and ChAT (1:100 dilution, #AB144P, Merck Millipore, Massachusetts, USA) diluted in PBSGT with 0.1% saponin for 14 days at 37 °C with mild agitation. After 14 days, the samples were rinsed 6 times over an entire day and incubated with anti-rabbit IgG Alexa Fluor® 647 (A-21443, Molecular Probes, Oregon, USA) and anti-goat IgG Alexa Fluor® 555 (A-21432, Molecular Probes, Oregon, USA). Secondary antibodies solution was filtered through a 0.22 µm syringe filter and incubated for 48 hours in PBSGT with 0.1% saponin at 37 °C with mild agitation. The samples were then rinsed 6 times with PBS over an entire day. Then, we performed the 3DISCO clearing protocol as previously described12,13. Briefly, the samples were incubated in the dark at room temperature in different concentrations of tetrahydrofuran (THF) diluted in water for 1.5 hours each (50% of THF, 80% of THF and two incubation in 100% THF) and then in dichloromethane (DCM) for 30 minutes followed by dibenzyl ether (DBE) for at least three hours. Images were acquired with an UltraMicroscope I (LaVision BioTec-Miltenyi, Bielefeld, Germany) assisted by Imspector Pro software (LaVision BioTec-Miltenyi Bielefeld, Germany). The light sheet created by two cylindrical lenses was generated by a laser with 2 specific wavelengths: 561 nm and 640 nm (Coherent Sapphire Laser, LaVision BioTec-Miltenyi). A protective dipping cap with a corrective lens was used for all acquisitions, and a binocular stereomicroscope (MXV10, Olympus) with a 2x objective (MVPLAPO, Olympus) was used. Samples were placed in a quartz tank (LaVision BioTec-Miltenyi) filled with DBE, and the illumination came from both sides. A Zyla SCMOS camera (2,048 × 2,048 pixels, Andor, Oxford Instruments) was used to acquire images. The step size between each image was fixed at 2 μm (NA = 0.5, 150 ms exposure). All images are generated as 16-bit.tiff files.
3D reconstructions are generated using the ImarisFileConverter (version 9.1.2, Bitplane) as Imaris Files (.ims). For 3D visualization on Imaris software (version 9.1.2, Bitplane), we used “volume”. We altered the normal shading view to obtain opaque visualizations. Optical slices are generated using the “orthoslicer” tool. 3D pictures and movies were generated using the “snapshot” and “animation” tools. Movie reconstructions with.tiff files were generated with ImageJ (1.50e, Java 1.8.0_60, 64-bit). We added titles and transitions with iMovie (version 10.1.1).
Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745–1759 (2019).
Shibakawa, A. et al. The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthr. Cartil. 13, 679–687 (2005).
Zarka, M. et al. Microcracks in subchondral bone plate is linked to less cartilage damage. Bone 123, 1–7 (2019).
Lories, R. J. & Luyten, F. P. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7, 43–49 (2011).
Mahjoub, M., Berenbaum, F. & Houard, X. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporos Int 23(Suppl 8), S841–846 (2012).
Suri, S. et al. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann. Rheum. Dis. 66, 1423–1428 (2007).
Mapp, P. I. & Walsh, D. A. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 8, 390–398 (2012).
Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101 (2011).
Sato, T. et al. Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett. 584, 817–824 (2010).
Courties, A., Sellam, J. & Berenbaum, F. Role of the autonomic nervous system in osteoarthritis. Best Pract Res Clin Rheumatol 31, 661–675 (2017).
Belle, M. et al. A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system. Cell Rep 9, 1191–1201 (2014).
Belle, M. et al. Tridimensional Visualization and Analysis of Early Human Development. Cell 169, 161–173.e12 (2017).
Jing, D. et al. Tissue Clearing and Its Application to Bone and Dental Tissues. J. Dent. Res. 98, 621–631 (2019).
Jing, D. et al. Tissue clearing of both hard and soft tissue organs with the PEGASOS method. Cell Res. 28, 803–818 (2018).
Bajayo, A. et al. Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc. Natl. Acad. Sci. USA 109, 15455–15460 (2012).
Asmus, S. E., Parsons, S. & Landis, S. C. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J. Neurosci. 20, 1495–1504 (2000).
Stangl, H., Springorum, H.-R., Muschter, D., Grässel, S. & Straub, R. H. Catecholaminergic-to-cholinergic transition of sympathetic nerve fibers is stimulated under healthy but not under inflammatory arthritic conditions. Brain Behav. Immun. 46, 180–191 (2015).
Asmus, S. E., Tian, H. & Landis, S. C. Induction of cholinergic function in cultured sympathetic neurons by periosteal cells: cellular mechanisms. Dev. Biol. 235, 1–11 (2001).
Landis, S. C. The development of cholinergic sympathetic neurons: a role for neuropoietic cytokines? Perspect Dev Neurobiol 4, 53–63 (1996).
Lips, K. S. et al. Small changes in bone structure of female α7 nicotinic acetylcholine receptor knockout mice. BMC Musculoskelet Disord 16, 5 (2015).
Lips, K. S. et al. Altered ultrastructure, density and cathepsin K expression in bone of female muscarinic acetylcholine receptor M3 knockout mice. Int. Immunopharmacol. 29, 201–207 (2015).
Vigouroux, R. J., Belle, M. & Chédotal, A. Neuroscience in the third dimension: shedding new light on the brain with tissue clearing. Mol Brain 10, 33 (2017).
Ertürk, A. et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat Protoc 7, 1983–1995 (2012).
Renier, N. et al. iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896–910 (2014).
This work was supported by the French Society of Rheumatology (SFR) and the Assistance Publique - Hôpitaux de Paris (AP-HP).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Courties, A., Belle, M., Senay, S. et al. Clearing method for 3-dimensional immunofluorescence of osteoarthritic subchondral human bone reveals peripheral cholinergic nerves. Sci Rep 10, 8852 (2020). https://doi.org/10.1038/s41598-020-65873-6